Shares of agilon health, inc. (NYSE:AGL - Get Free Report) have been assigned a consensus recommendation of "Hold" from the nineteen ratings firms that are currently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and five have issued a buy rating on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $4.79.
Several equities research analysts have recently weighed in on AGL shares. Sanford C. Bernstein upgraded shares of agilon health from a "market perform" rating to an "outperform" rating and increased their price objective for the stock from $3.30 to $8.50 in a research report on Tuesday, April 8th. TD Cowen increased their price objective on shares of agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a research report on Tuesday, April 15th. JMP Securities reiterated a "market perform" rating on shares of agilon health in a research report on Monday, April 28th. Cowen restated a "hold" rating on shares of agilon health in a report on Tuesday, April 15th. Finally, Stifel Nicolaus raised their price target on shares of agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a report on Wednesday, February 26th.
Read Our Latest Stock Analysis on agilon health
Institutional Trading of agilon health
Several hedge funds have recently added to or reduced their stakes in AGL. Ieq Capital LLC bought a new stake in agilon health in the fourth quarter worth about $26,000. Signaturefd LLC raised its position in shares of agilon health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after purchasing an additional 8,467 shares during the period. Humankind Investments LLC bought a new stake in shares of agilon health in the fourth quarter valued at approximately $30,000. Raymond James Financial Inc. bought a new stake in shares of agilon health in the fourth quarter valued at approximately $33,000. Finally, Cerity Partners LLC bought a new stake in shares of agilon health in the fourth quarter valued at approximately $34,000.
agilon health Trading Down 4.9%
Shares of AGL stock traded down $0.12 during trading hours on Friday, hitting $2.24. 5,382,205 shares of the company's stock traded hands, compared to its average volume of 4,960,961. The stock's 50 day simple moving average is $3.83 and its 200 day simple moving average is $3.17. The stock has a market cap of $925.18 million, a PE ratio of -2.38 and a beta of 0.38. agilon health has a 12 month low of $1.50 and a 12 month high of $7.73. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.
agilon health (NYSE:AGL - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.50 billion. During the same period in the prior year, the company posted ($0.02) earnings per share. agilon health's revenue for the quarter was down 4.5% compared to the same quarter last year. On average, sell-side analysts anticipate that agilon health will post -0.59 EPS for the current year.
agilon health Company Profile
(
Get Free Reportagilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Further Reading

Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.